Your browser doesn't support javascript.
loading
Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.
Rodríguez-Arbolí, Eduardo; Othus, Megan; Orvain, Corentin; Zarling, Lucas C; Sandmaier, Brenda M; Milano, Filippo; Schoch, Gary; Davis, Chris; Deeg, H Joachim; Appelbaum, Frederick R; Storb, Rainer; Walter, Roland B.
Afiliação
  • Rodríguez-Arbolí E; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Seville, Seville.
  • Othus M; Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Orvain C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Zarling LC; Department of Medicine, Residency Program, University of Washington, Seattle, WA.
  • Sandmaier BM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA.
  • Milano F; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA.
  • Schoch G; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Davis C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Deeg HJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA.
  • Appelbaum FR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA.
  • Storb R; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA.
  • Walter RB; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA; Department of Epidemiology, University
Haematologica ; 108(1): 273-277, 2023 01 01.
Article em En | MEDLINE | ID: mdl-36134457
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article